Literature DB >> 28061531

Effects of circadian rhythms and treatment times on the response of radiotherapy for painful bone metastases.

Stephanie Chan1, Liying Zhang1, Leigha Rowbottom1, Rachel McDonald1, Georg A Bjarnason1, May Tsao1, Elizabeth Barnes1, Cyril Danjoux1, Marko Popovic1, Henry Lam1, Carlo DeAngelis1, Edward Chow2.   

Abstract

BACKGROUND: Previous studies have observed how the time of radiotherapy delivery can impact toxicities and outcomes. The goal of this study was to determine whether treatment time influenced radiotherapy response for bone metastases.
METHODS: Patients who received radiation treatment to painful bone metastases from January 2000 to December 2010 were included in our analysis. Demographic and treatment information including performance status, primary site, treatment dose and fraction, and response were collected prospectively. Treatment times were extracted from patient medical records. Patients were allocated to 8:00 AM-11:00 AM, 11:01 AM-2:00 PM, or 2:01 PM-5:00 PM cohorts based on their treatment times. To compare treatment response between the three cohorts, the Fisher exact test was used. A two-sided P value of <0.05 was considered statistically significant. Analysis was repeated with males and females separately.
RESULTS: A total of 194 patients were included. The median age was 68 years and 55.5% of patients responded to treatment. The dose and fraction of radiation received differed significantly between treatment cohorts using all allocation methods. Females in the 11:01 AM-2:00 PM cohort exhibited a significantly higher response rate (P=0.02) and differing proportions of response types (P=0.03) compared to the 8:00 AM- 11:00 AM and 2:01 PM-5:00 PM cohorts when allocated using all treatment times. No significant differences in response were seen between cohorts when all patients were analysed together or analysed for males only.
CONCLUSIONS: Treatment time may affect response in female patients receiving radiotherapy for painful bone metastases. Subsequent chronotherapy studies in radiation should investigate these gender differences.

Entities:  

Keywords:  Chronotherapy; bone metastases; circadian rhythms; radiotherapy; treatment response

Mesh:

Year:  2016        PMID: 28061531     DOI: 10.21037/apm.2016.09.07

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  11 in total

1.  Radiation chronotherapy-clinical impact of treatment time-of-day: a systematic review.

Authors:  Dorela D Shuboni-Mulligan; Ghislain Breton; DeeDee Smart; Mark Gilbert; Terri S Armstrong
Journal:  J Neurooncol       Date:  2019-11-15       Impact factor: 4.130

Review 2.  Systems Chronotherapeutics.

Authors:  Annabelle Ballesta; Pasquale F Innominato; Robert Dallmann; David A Rand; Francis A Lévi
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 3.  Cancer and the Circadian Clock.

Authors:  Ayesha A Shafi; Karen E Knudsen
Journal:  Cancer Res       Date:  2019-07-12       Impact factor: 12.701

Review 4.  Circadian Rhythms, Disease and Chronotherapy.

Authors:  Yool Lee; Jeffrey M Field; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2021-09-22       Impact factor: 3.649

Review 5.  Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.

Authors:  Narin Ozturk; Dilek Ozturk; Ibrahim Halil Kavakli; Alper Okyar
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

6.  mRNA and lncRNA Expression Profiling of Radiation-Induced Gastric Injury Reveals Potential Radiation-Responsive Transcription Factors.

Authors:  Guangxia Chen; Yang Feng; Zhiqiang Sun; Yiying Gao; Chuannan Wu; Haihan Zhang; Jinming Cao; Zhuo Chen; Jianping Cao; Yaqun Zhu; Shuyu Zhang
Journal:  Dose Response       Date:  2019-11-07       Impact factor: 2.658

Review 7.  Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas.

Authors:  Han Shen; Kristina Cook; Harriet E Gee; Eric Hau
Journal:  J Exp Clin Cancer Res       Date:  2020-07-07

8.  The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.

Authors:  Ayesha A Shafi; Chris M McNair; Jennifer J McCann; Mohammed Alshalalfa; Anton Shostak; Tesa M Severson; Yanyun Zhu; Andre Bergman; Nicolas Gordon; Amy C Mandigo; Saswati N Chand; Peter Gallagher; Emanuela Dylgjeri; Talya S Laufer; Irina A Vasilevskaya; Matthew J Schiewer; Michael Brunner; Felix Y Feng; Wilbert Zwart; Karen E Knudsen
Journal:  Nat Commun       Date:  2021-01-15       Impact factor: 14.919

Review 9.  Clock at the Core of Cancer Development.

Authors:  Sonal A Patel; Roman V Kondratov
Journal:  Biology (Basel)       Date:  2021-02-14

10.  Biodistribution of 131I in mice is influenced by circadian variations.

Authors:  Charlotte K Andersson; Mikael Elvborn; Johan K E Spetz; Britta Langen; Eva B Forssell-Aronsson
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.